Brand-name drug
Lybalvi price, strengths & recalls
Brand of olanzapine / samidorphan (generic)
Pharmacies pay $1,655.86 for 30 tablets of Lybalvi 5 mg / 10 mg tablet this week, and from $1,649.02 to $1,655.86 across its 4 priced strengths and forms. Its official label last changed on February 16, 2026.
Brand- Fair cash price
- $1,914.74
- Strengths
- 4
- Makers
- 1
- Updated
- Nov 11
Lybalvi price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 5 mg / 10 mg tablet Brand | $55.20 | $1,655.86 / 30 tablets |
| 10 mg / 10 mg tablet Brand | $55.11 | $1,653.29 / 30 tablets |
| 15 mg / 10 mg tablet Brand | $55.10 | $1,653.03 / 30 tablets |
| 20 mg / 10 mg tablet Brand | $54.97 | $1,649.02 / 30 tablets |
The lowest cost per tablet is 20 mg / 10 mg tablet at $54.97. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Lybalvi vs generic olanzapine / samidorphan
There is no generic version of Lybalvi on the market yet. Its last listed patent or exclusivity runs to November 12, 2041 - generics often follow, though court cases and settlements can move the date either way.
GenericOlanzapine / samidorphan pricesSupply status: shortages & recalls
What people paid for Lybalvi
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use LYBALVI® safely and effectively. See full prescribing information for LYBALVI®.LYBALVI® (olanzapine and samidorphan) tablets, for oral useInitial U.S. Approval: 2021
WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. LYBALVI is not approved for the treatment of patients with dementia-related psychosis
[see Warnings and Precautions (5.1)].
WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
See full prescribing information for complete boxed warning.
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. LYBALVI is not approved for the treatment of patients with dementia-related psychosis. (5.1)
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA213378 · Alkermes Inc
- First approved
- May 28, 2021 (5 years ago)
- Latest approved change
- January 30, 2026
- Approved label
- PDF, Feb 5, 2026
- Generic makers
- None on the market
- Last patent listed
- November 12, 2041
- Exclusivity ends
- May 28, 2026 (ended)
Patent dates are what the maker lists with FDA. Generic launch dates are often set by court rulings or settlements instead. Upcoming generics.
Lybalvi questions
How much does lybalvi cost without insurance?
Pharmacies pay about $1,655.86 for 30 tablets of lybalvi 5 mg / 10 mg tablet ($55.20 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $1,914.74. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is there a generic for Lybalvi?
Yes: olanzapine / samidorphan. Compare olanzapine / samidorphan prices.
Is lybalvi in shortage?
No shortage is reported for lybalvi right now. We check the national shortage list every day.
Has lybalvi been recalled?
No recalls are on record for lybalvi.
When did the lybalvi label last change?
The official label was last updated on February 16, 2026 (version 16). See what changed.
Talk about lybalvi
No comments yet. Questions, tips, what worked for you - start the conversation.